Boehringer forges $7bn alliance with China's SBP Group
Boehringer Ingelheim is paying $358m upfront for options on up to six antibody-drug conjugates and T cell engagers from China's Sino Biopharma.
Oral Wegovy bolsters Novo in Q3
Novo has raised its financial guidance for 2026 on the back of rising sales of its oral weight-loss therapy Wegovy.
UK women's health firm Theramex sold for around £2.2bn
Theramex, a UK-based specialty pharma company focusing on women's health, is changing hands in a private equity deal said to be worth around £2.2bn.
AbbVie invests £120m in UK expansion
AbbVie has pledged another £120 million to the UK, reinforcing the country's recovery as a pharma industry investment hotspot.
German sites added to Europe's cardiometabolic R&D network
The BioInnovation Institute (BII) has expanded a European network to develop drugs for cardiometabolic diseases and launch new biotechs into Germany.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
LEAP HR: Life Sciences Europe
Europe’s Only Industry-Specific Meeting Advancing HR Excellence in Life Sciences
Rational Based Drug Design Summit Europe
Driving Safer, Faster & More Efficient Discovery Across Europe
Evolution Summit 2027 to Convene Senior Clinical Development...
Westlake Village, CA: Marcus Evans today announced the Evolution Summit 2027, an invitation-only gathering of senior clinical trial executives
ISMAI 2026: Florence to host international symposium on the ...
On 3 and 4 December, in the CTO Auditorium of Careggi University Hospital, clinicians, scientists and international experts will discuss clinical judgement, patient safety and professional acco
11th Liquid Biopsy for Precision Oncology Summit West Coast
Your industry-leading, flagship West Coast meeting uniting the global liquid biopsy community